Latest Advisory

  • FDA Advisory No. 2017-329 || Voluntary Recall of  AV-Set B DT INF-E Blood Tubing System with DVR No. 8574 (Article No. AP16641)

    FDA Advisory No. 2017-329 || Voluntary Recall of AV-Set B DT INF-E Blood Tubing System with DVR No. 8574 (Article No. AP16641)

    Read more

  • FDA Advisory No. 2017-328 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 20)

    FDA Advisory No. 2017-328 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 20)

    Read more

  • FDA Advisory No. 2017-327 || CREATION OF A TASK FORCE THAT WILL REVIEW, SUBMIT RECOMMENDATIONS AND TAKE APPROPRIATE ACTIONS RELATING TO THE DENGUE TETRAVALENT VACCINE (LIVE, ATTENUATED), REGISTERED AS DENGVAXIA, AND THE TRANSMITTAL OF APPLICATIONS, LETTER

    FDA Advisory No. 2017-327 || CREATION OF A TASK FORCE THAT WILL REVIEW, SUBMIT RECOMMENDATIONS AND TAKE APPROPRIATE ACTIONS RELATING TO THE DENGUE TETRAVALENT VACCINE (LIVE, ATTENUATED), REGISTERED AS DENGVAXIA, AND THE TRANSMITTAL OF APPLICATIONS, LETTER

    Read more

  • FDA Advisory No. 2017-326 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product:

    FDA Advisory No. 2017-326 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product:

    Read more

  • FDA Advisory No. 2017-322 || TERMINATION OF THE VOLUNTARY PRODUCT RECALLOF COBRA DISTAL RADIUS FIXATOR

    FDA Advisory No. 2017-322 || TERMINATION OF THE VOLUNTARY PRODUCT RECALLOF COBRA DISTAL RADIUS FIXATOR

    Read more

  • FDA Advisory No. 2017-325 || VOLUNTARY RECALL OF THE NASOPORE STANDARD 8CM NASAL DRESSING WITH PRODUCT REGISTRATION MDR NO. 02341

    FDA Advisory No. 2017-325 || VOLUNTARY RECALL OF THE NASOPORE STANDARD 8CM NASAL DRESSING WITH PRODUCT REGISTRATION MDR NO. 02341

    Read more

  • FDA Advisory No. 2017-323 || Public Health Warning Against False, Deceptive and Misleading Health Claims of Pantyliners

    FDA Advisory No. 2017-323 || Public Health Warning Against False, Deceptive and Misleading Health Claims of Pantyliners

    Read more

  • FDA Advisory No. 2017-321 || Public Health Warning Against the Purchase and Use of Unregistered Medical Device “Firstaid Blood Lancets”

    FDA Advisory No. 2017-321 || Public Health Warning Against the Purchase and Use of Unregistered Medical Device “Firstaid Blood Lancets”

    Read more

  • FDA Advisory No. 2017-320 || Public Health Warning Against the Use of Unregistered Medical Device (Sutures)

    FDA Advisory No. 2017-320 || Public Health Warning Against the Use of Unregistered Medical Device (Sutures)

    Read more

  • FDA Advisory No. 2017-324-A || Mga Paalala sa Publiko Ngayong Panahon ng Pasko

    FDA Advisory No. 2017-324-A || Mga Paalala sa Publiko Ngayong Panahon ng Pasko

    Read more

  • FDA Advisory No. 2017-324 || Reminders to the Public During the Holiday Season

    FDA Advisory No. 2017-324 || Reminders to the Public During the Holiday Season

    Read more

  • FDA Advisory No. 2017-319 || Public Health Warning Against the Purchase and Consumption of Unregistered and Unfortified Flour Products

    FDA Advisory No. 2017-319 || Public Health Warning Against the Purchase and Consumption of Unregistered and Unfortified Flour Products

    Read more

  • FDA Advisory No. 2017-316 || Public Health Warning Against the Purchase and Consumption   of the following Unregistered and Unfortified Food Oil  Products:

    FDA Advisory No. 2017-316 || Public Health Warning Against the Purchase and Consumption of the following Unregistered and Unfortified Food Oil Products:

    Read more

  • FDA Advisory No. 2017-318 || Suspension of Sale/Marketing/Distribution of Sanofi Pasteur, Inc.’s Tetravalent Vaccine (Live, Attenuated)(Dengvaxia)

    FDA Advisory No. 2017-318 || Suspension of Sale/Marketing/Distribution of Sanofi Pasteur, Inc.’s Tetravalent Vaccine (Live, Attenuated)(Dengvaxia)

    Read more

  • FDA Advisory No. 2017-317 || ACCEPTANCE OF ALL APPLICATIONS AT THE FOOD AND DRUG ACTION CENTER (FDAC) CASHIER

    FDA Advisory No. 2017-317 || ACCEPTANCE OF ALL APPLICATIONS AT THE FOOD AND DRUG ACTION CENTER (FDAC) CASHIER

    Read more

  • FDA Advisory No. 2017-315 || Voluntary Recall of BD Vacutainer K2 EDTA (K2E) 3.6mg Blood Collection Tube, 13 x 75mm x 2.0mL

    FDA Advisory No. 2017-315 || Voluntary Recall of BD Vacutainer K2 EDTA (K2E) 3.6mg Blood Collection Tube, 13 x 75mm x 2.0mL

    Read more

  • FDA Advisory No. 2017-314 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 67)

    FDA Advisory No. 2017-314 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 67)

    Read more

  • FDA Advisory No. 2017-313 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 13)

    FDA Advisory No. 2017-313 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 13)

    Read more

  • FDA Advisory No. 2017-312 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 12)

    FDA Advisory No. 2017-312 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 12)

    Read more

  • FDA Advisory No. 2017-311 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    FDA Advisory No. 2017-311 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    Read more

FDA Circular No. 2016-018

New FDA Director General

In the interest of continuing public service to the consumers, industries, other government agencies and concerned parties, you are hereby informed that the new Director General of the Food and Drug Administration effective 19 August 2016, is:

NELA CHARADE G. PUNO, RPh
FDA Director General
Department of Health

For your information and guidance

 

Public Consultation on the Draft Implementing Rules and Regulations of Republic Act No. 10918, otherwise known as the Philippine Pharmacy Act

On 21 July 2016, Republic Act (RA)No. 10918, otherwise known as the Philippine Pharmacy Act, was passed with the following objectives:

 

To continue reading download the attachment...

 

 

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter